Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human EMR2 ELISA Kit
Click to view available options
Quantity:
5 x 96 Tests
96 Tests
Description
Human EMR2 quantitates human EMR2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human EMR2.
EMR3 gene encodes a member of the class B seven-span transmembrane (TM7) receptor family expressed predominantly by cells of the immune system. Family members are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor (EGF)-like domains coupled to a TM7 domain via a mucin-like spacer domain. This gene is closely linked to the gene encoding egf-like molecule containing mucin-like hormone receptor 2 on chromosome 19. This protein may play a role in myeloid-myeloid interactions during immune and inflammatory responses.
Specifications
Specifications
| Accession Number | ADGRE2; adhesion G protein-coupled receptor E2; CD312; CD312 antigen; egf-like module containing, mucin-like, hormone receptor-like 2; EGF-like module receptor 2; EGF-like module-containing mucin-like hormone receptor-like 2; EMR2; VBU |
| Assay Range | 18 to 4,000 pg/mL |
| Assay Sensitivity | 18 pg/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Sample Type | Plasma, Serum, Supernatant |
| For Use With (Equipment) | Colorimetric Microplate Reader |
| Gene ID (Entrez) | 30817 |
| Gene Symbol | ADGRE2 |
| Interassay CV | <12% |
| Show More |
Safety and Handling
WARNING: Reproductive Harm - www.P65Warnings.ca.gov
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction